Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 27, 2013Radiation OncologyOpen Access

Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

LTLingli TuLSLan SunJiangsu Food and Pharmaceutical Science CollegeYXYong XuCentral South University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tu et al. (2013) studied this question.

synapsesocial.com/papers/6a86c61dcbc6304817beee63https://doi.org/10.1186/1748-717x-8-75
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study2006 · 127 citations
  2. 2Phase I Trial of Combined-Modality Therapy for Localized Esophageal Cancer: Escalating Doses of Continuous-Infusion Paclitaxel With Cisplatin and Concurrent Radiation Therapy2003 · 65 citations
  3. 3Surgical Management of Carcinoma of the Hypopharynx and Cervical Esophagus2001 · 220 citations
  4. 4INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy2002 · 1,347 citations